Crossmark

N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma

Published Online: 2021-08-13

Published Print: 2021-12

Authors

Cai, Jihao https://orcid.org/0000-0002-8935-8708
Zhou, Minglei

Xu, Jianxin
License Information

Text and Data Mining valid from 2021-08-13

Version of Record valid from 2021-08-13
More Information

Article History

Received: 6 June 2021

Accepted: 1 August 2021

First Online: 13 August 2021

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current